b ackg r oun d : multi-drug resistant strains of acinetobacter spp. have created therapeutic problems worldwide. the objective of this study was to detect integrons  in acinetobacter   spp. isolates  from ventilator-associated  pneu- monia patients using pcr method. me t ho d s : a total 51 bronchoalveolar lavage samples were obtained from patients in icu and examined for acinetobacter spp. inf...

Clinical diagnosis of ventilator-associated pneumonia . . . . . . . . . . . . . . . . . . . . . . . . . . 1034 Bacteriological and histological aspects of ventilator-associated pneumonia . . . . . . . . . . . . 1035 Aetiology of ventilator-associated pneumonia . . . . . . . . . . . . . . . . . . . . . . . . . . 1036 Diagnostic techniques for ventilator-associated pneumonia . . . . . . . . . . ....

introduction:ventilator- associated pneumonia(vap),as defined by the centers for disease control and prevention (cdc),is a pneumonia that occurs in a patient receiving mechanical ventilation that develops 48 hours or more after initiation of ventilation.re-intubation which occur within 72 hours of planned extubation may effect vap incidence.the aim of this study was to determine vap incidence i...

Ventilator-associated pneumonia is a common nosocomial infection that results in both negative patient outcomes and increased health care costs. Recently, many efforts have been targeted at ventilator-associated pneumonia prevention, including the practice of subglottic secretion aspiration. Six randomized control studies examining the effectiveness of subglottic secretion aspiration in the pre...

background: ventilator-associated pneumonia (vap) is a type of nosocomial pneumonia which develops more than 48 hours after endotracheal intubation. early recognition and treatment of vap is important, since timely and appropriate management can be lifesaving. objectives: this study aimed to determine the antimicrobial susceptibility pattern of microorganisms causing vap in the intensive care u...

background ventilator- associated pneumonia (vap) continues to complicate the course of 8-28 % patients receiving mechanical ventilation. the mortality rate for vap is high, ranges from 24-50% and can reach 76% in some specific settings or when lung infection is caused by high risk pathogens. the etiologic agents widely differ according to the population of patients in an intensive care unit, d...

0

background: ventilator-associated pneumonia (vap) is the most prevalent and lethal form of nosocomial infections in the icu and oral disinfection is a nursing measure to prevent this condition. aim: this study aimed to evaluate the effect of oronasal versus oral disinfections with chlorhexidine on the clinical criteria for diagnosis of vap. method: this randomized clinical trial was conducted o...